1 / 11

Renal Biomarker Market

Global Renal Biomarker Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

omrglobal
Download Presentation

Renal Biomarker Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Renal Biomarker Market Research and Forecast 2018-2023 Biotechnology Pharmaceuticals

  2. DEFINITION Kidney diseases or renal diseases is one of the major causes of deaths across the globe. The incidence of the renal diseases, particularly in geriatric population is rising rapidly owing to better life expectancy due to improvements in medical systems. Diabetes and high blood pressure are the leading cause of renal disease. A biomarker is an indicator of a specific biological state, relevant to the risk for, the presence of, or the stage of any disease. Biomarkers are clinically used for various purpose such as screening, diagnosing, or monitoring the activity of any diseases.

  3. MARKET MOTIVATORS • Rising prevalence of various kidney related diseases • Sparking innovation to improve the lives of people with kidney disease • High population pool of diabetes and blood pressure- leading cause of renal disease • Kidney injury biomarkers: value in drug development • Awareness programmes for acute kidney injury(AKI)

  4. MARKET RESTRAINTS • Lack of regulatory & reimbursement systems • Limited market capabilities in underdeveloped markets

  5. MARKET OPPORTUNITIES • Growing trend towards personalized medicine • Rising demand from emerging economies

  6. REGIONAL ANALYSIS

  7. MARKET SEGMENTATION By type • Diagnostic biomarkers • Prognostic biomarkers • Predictive biomarkers • Pharmacodynamic biomarkers

  8. MARKET SEGMENTATION By diagnostic technique • Elisa • Colorimetric assay • Liquid chromatography-mass spectrometry • Particle-enhanced turbidimetric immunoassay

  9. MARKET SEGMENTATION By end users • Hospitals • Diagnostic labs • Research centres

  10. COMPANY PROFILE • Abbott laboratories • Astellas pharma inc. • Astute medical, inc. • Bayer ag • Beckman coulter inc. To be continued……

  11. FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global)116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya PradeshIndia- 452010 Global +1 646-755-7667 Asia +91 917-982-8694 info@omrglobal.com https://www.omrglobal.com CONTACT US 11

More Related